Table 1 Distribution of patients’ characteristics among both groups (n = 438)
All patients (n = 438) | Foreigners (n = 219) | German (n = 219) | ||||||
|---|---|---|---|---|---|---|---|---|
n | % | n | % | p-value | chi-square | |||
Age (years) | ||||||||
< 60 | 127 | 58.0 | 114 | 52.1 | ||||
≥ 60 | 92 | 42.0 | 105 | 47.9 | 0.211 | |||
Median | 55.1 | 58.6 | 0.01 | |||||
Range | Min. = 20 Max. = 93 | Min. = 24 Max. = 94 | ||||||
Sex | ||||||||
Male | 123 | 56.2 | 124 | 56.6 | ||||
Female | 96 | 43.8 | 95 | 43.4 | 0.923 | |||
Follow-up (months) | ||||||||
Median | 14.5 | 17.9 | 0.001 | |||||
Range | Min. = 0.1 Max. = 34.5 | Min. = 0.3 Max. = 73.8 | ||||||
All patients with solid tumors (n = 382) | Foreigners (n = 141) | German (n = 141) | ||||||
n | % | n | % | |||||
UICC | ||||||||
0 | 2 | 1.4 | 2 | 1.4 | 0.979 | |||
I | 28 | 19.9 | 25 | 17.7 | ||||
II | 12 | 8.5 | 13 | 9.2 | ||||
III | 16 | 11.3 | 20 | 14.2 | ||||
IV | 36 | 25.5 | 37 | 26.2 | ||||
X | 47 | 33.3 | 44 | 31.2 | ||||
Total | 141 | 100.0 | 141 | 100.0 | ||||
WHO brain | ||||||||
I | 0 | 0 | 0 | 0 | 1.000 | |||
II | 1 | 7.7 | 1 | 7.7 | ||||
III | 2 | 15.4 | 2 | 15.4 | ||||
IV | 10 | 76.9 | 10 | 76.9 | ||||
Total | 13 | 100.0 | 13 | 100.0 | ||||
FIGO | ||||||||
DCIS | 3 | 8.1 | 3 | 8.1 | 0.998 | |||
I | 7 | 18.9 | 8 | 21.6 | ||||
II | 6 | 16.2 | 4 | 10.8 | ||||
III | 3 | 8.1 | 3 | 8.1 | ||||
IV | 4 | 10.8 | 4 | 10.8 | ||||
X | 14 | 37.8 | 15 | 40.5 | ||||
Total | 37 | 100.0 | 37 | 100.0 | ||||
Additionally Scores | ||||||||
Gleason | ||||||||
6 | 1 | 10.0 | 1 | 10.0 | 0.878 | |||
7 | 3 | 30.0 | 3 | 30.0 | ||||
8 | 3 | 30.0 | 2 | 20.0 | ||||
9 | 3 | 30.0 | 3 | 30.0 | ||||
X | 0 | 0.0 | 1 | 10.0 | ||||
Total | 10 | 100.0 | 10 | 100.0 | ||||
Clark Level | ||||||||
I | 0 | 0.0 | 0 | 0.0 | 0.315 | |||
II | 0 | 0.0 | 0 | 0.0 | ||||
III | 2 | 25.0 | 3 | 37.5 | ||||
IV | 4 | 50.0 | 5 | 62.5 | ||||
X | 2 | 25.0 | 0 | 0 | ||||
All patients with malignant hematological diseases (n = 56) | ||||||||
Foreigners (n = 28) | German (n = 28) | |||||||
n | % | n | % | |||||
Lymphoma | 13 | 46.4 | 13 | 46.4 | 1.000 | |||
Leukemia | 8 | 28.6 | 8 | 28.6 | ||||
Multiple Myeloma | 7 | 25.0 | 7 | 25.0 | ||||
Ann Arbor | ||||||||
I | 1 | 7.7 | 2 | 15.4 | 0.829 | |||
II | 1 | 7.7 | 2 | 15.4 | ||||
III | 0 | 0.0 | 0 | 0.0 | ||||
IV | 7 | 53.8 | 6 | 46.2 | ||||
X | 4 | 30.8 | 3 | 23.1 | ||||
Total | 13 | 100.0 | 13 | 100.0 | ||||
Durie and Salmon | ||||||||
I | 0 | 0.0 | 0 | 0.0 | 0.135 | |||
II | 1 | 14.3 | 1 | 14.3 | ||||
III | 3 | 42.9 | 6 | 85.7 | ||||
X | 3 | 42.9 | 0 | 0 | ||||
Total | 7 | 100.0 | 7 | 100.0 | ||||
Binet | ||||||||
A | 2 | 100.0 | 2 | 100.0 | 1.000 | |||
B | 0 | 0.0 | 0 | 0.0 | ||||
C | 0 | 0.0 | 0 | 0.0 | ||||
X | 0 | 0.0 | 0 | 0.0 | ||||